DIO Corporation (KOSDAQ:039840)
17,440
+250 (1.45%)
Apr 1, 2025, 3:30 PM KST
DIO Corporation Revenue
In the year 2024, DIO Corporation had annual revenue of 119.65B KRW, down -23.21%. DIO Corporation had revenue of 37.80B in the quarter ending December 31, 2024, with 23.08% growth.
Revenue
119.65B
Revenue Growth
-23.21%
P/S Ratio
2.07
Revenue / Employee
264.71M
Employees
452
Market Cap
237.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 119.65B | -36.17B | -23.21% |
Dec 31, 2023 | 155.82B | 24.51B | 18.67% |
Dec 31, 2022 | 131.31B | -18.73B | -12.48% |
Dec 31, 2021 | 150.04B | 29.98B | 24.97% |
Dec 31, 2020 | 120.06B | -7.11B | -5.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |